v3.26.1
Cash, Cash Equivalents, and Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2026
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Investments
The following table shows the Company’s cash, cash equivalents, and marketable securities by significant investment category as of March 31, 2026 and December 31, 2025:
As of March 31, 2026
Adjusted Cost Total Unrealized GainsFair ValueCash and Cash EquivalentsMarketable Securities
(in thousands)
Cash$193,430 $— $193,430 $193,430 $— 
Level 1:
Money market funds43,069 — 43,069 43,069 — 
Level 2:
U.S. treasury securities19,170 5 19,175 — 19,175 
Total$255,669 $5 $255,674 $236,499 $19,175 

As of December 31, 2025
Adjusted Cost Total Unrealized GainsFair ValueCash and Cash EquivalentsMarketable Securities
(in thousands)
Cash$194,182 $— $194,182 $194,182 $— 
Level 1:
Money market funds62,034 — 62,034 62,034 — 
Level 2:
U.S. treasury securities19,405 29 19,434 — 19,434 
Total$275,621 $29 $275,650 $256,216 $19,434